Please be advised: MSK has not registered to be a designated vaccine site for the general public at this time. Two MSK locations were incorrectly listed and we have contacted the New York State Department of Health to update their website.
I am an attending physicist and co-director of our small-animal imaging laboratories and serve as Chairman of its Committee on Radiation. I am also a Special Contributing Faculty Member of the Gerstner Sloan Kettering Graduate School.
I am actively involved in biomedical research on radionuclide-based methods for detecting and localizing tumor hypoxia (oxygen deprivation), immune effector-cell trafficking, patient-specific dosimetry for radiation therapies, and small-animal and molecular imaging.
Medical physicist Pat Zanzonico focuses on radionuclide-based methods for detecting and localizing tumor hypoxia, immune effector-cell trafficking, patient-specific dosimetry for radionuclide therapies, and small-animal and molecular imaging.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Pat B. Zanzonico discloses the following relationships and financial interests:
Petrone Associates Provision of Services
Y-mAbs Therapeutics, Inc. Intellectual Property Rights
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at email@example.com.